# EDGAR Filing Document

**Accession Number:** 0001467808
**File Stem:** 0000929638-23-000665
**Filing Date:** 2023-2
**Character Count:** 4344
**Document Hash:** ec4ca0d33cefcf083e167bffd758c891
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000929638-23-000665.hdr.sgml**: 20230217

**ACCESSION NUMBER**: 0000929638-23-000665

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230217

**FILED AS OF DATE**: 20230217

**DATE AS OF CHANGE**: 20230217

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Global Cord Blood Corp
- **CENTRAL INDEX KEY:** 0001467808
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
- **IRS NUMBER:** 000000000

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34541
- **FILM NUMBER:** 23644178

**BUSINESS ADDRESS:**
- **STREET 1:** 48 FL., BANK OF CHINA TOWER
- **STREET 2:** 1 GARDEN ROAD
- **CITY:** CENTRAL HONG KONG
- **STATE:** K3
- **ZIP:** 000000
- **BUSINESS PHONE:** 852-3605-8180

**MAIL ADDRESS:**
- **STREET 1:** 48 FL., BANK OF CHINA TOWER
- **STREET 2:** 1 GARDEN ROAD
- **CITY:** CENTRAL HONG KONG
- **STATE:** K3
- **ZIP:** 000000

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** China Cord Blood Corp
- **DATE OF NAME CHANGE:** 20090707

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### WASHINGTON, D.C. 20549

### FORM 6-K

#### REPORT OF FOREIGN PRIVATE ISSUER

#### PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

#### THE SECURITIES EXCHANGE ACT OF 1934

#### For the month of February 2023<br>

#### Commission File Number: 001-34541

### GLOBAL CORD BLOOD CORPORATION
(Translation of registrant's name into English)

#### 48th Floor, Bank of China Tower

#### 1 Garden Road

#### Central

#### Hong Kong S.A.R.
(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

------

#### Introductory Note

On September 22, 2022, the Grand Court of the Cayman Islands (the "Court") issued an order (the "Order") appointing Margot MacInnis and John Royle of Grant Thornton Specialist Services (Cayman) Limited, and Chow Tsz Nga Georgia of Grant Thornton Recovery & Reorganisation Limited (such Grant Thornton entities, together "Grant Thornton"), as joint provisional liquidators (the "JPLs") of Global Cord Blood Corporation (the "Company") pursuant to Section 104(2) of the Companies Act (as amended) of the Cayman Islands.

#### Changes to Global Cord Blood Corporation's Board of Directors

On February 16, 2023, acting pursuant to the Order and a further order of the Court dated February 14, 2023 (the "Board Order"), the JPLs removed all existing members (Albert Chen, Ting Zheng, Mark D Chen, Dr Ken Lu, Jennifer J Weng, Jack Chow, Jacky Cheng and Xu Ping) of the Board of Directors of the Company (the "Board") and appointed in their place Sandipan Bhowmik, Denny Cheuk Kai Tse and Nigel Valentino Trayers (the "Replacement Directors"), each of whom is also associated with Grant Thornton, as members of the Board.

Notwithstanding their removal as directors of the Company, Albert Chen, Ting Zheng, Mark D Chen, Dr Ken Lu, Jennifer J Weng, Jack Chow and Jacky Cheng (the "Former Litigation Steering Committee") continue to be able to cause the Company to defend the ongoing Cayman Islands Winding-Up Petition proceedings bearing cause number FSD 108 of 2022 (IKJ) (the "Cayman Islands Winding-Up Petition Proceedings") and to engage attorneys and counsel for such purposes, subject to any determination of the Cayman Islands Court.

Nothing in the Board Order prevents or otherwise prejudices the Company's ongoing defense of the Cayman Islands Winding-Up Petition Proceedings.

------

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| **GLOBAL CORD BLOOD CORPORATION** | **GLOBAL CORD BLOOD CORPORATION** |
| By: | /s/ John Royle |
| Name: <br>| John Royle |
| Title: | Joint Provisional Liquidator by Order of the Grand Court of the Cayman Islands |

---

Dated: February 17, 2023<br>